- Home
- VRME vs CHRO Comparison
VRME vs CHRO Comparison
Compare VRME & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRME
- CHRO
- Stock Information
- Founded
- VRME 1999
- CHRO 2002
- Country
- VRME United States
- CHRO United States
- Employees
- VRME N/A
- CHRO N/A
- Industry
- VRME EDP Services
- CHRO
- Sector
- VRME Technology
- CHRO
- Exchange
- VRME Nasdaq
- CHRO Nasdaq
- Market Cap
- VRME 9.9M
- CHRO 10.7M
- IPO Year
- VRME N/A
- CHRO 2024
- Fundamental
- Price
- VRME $0.66
- CHRO $1.34
- Analyst Decision
- VRME Buy
- CHRO Strong Buy
- Analyst Count
- VRME 1
- CHRO 1
- Target Price
- VRME $1.25
- CHRO N/A
- AVG Volume (30 Days)
- VRME 454.2K
- CHRO 10.6K
- Earning Date
- VRME 03-06-2025
- CHRO 03-27-2025
- Dividend Yield
- VRME N/A
- CHRO N/A
- EPS Growth
- VRME N/A
- CHRO N/A
- EPS
- VRME N/A
- CHRO N/A
- Revenue
- VRME $24,207,000.00
- CHRO N/A
- Revenue This Year
- VRME $9.44
- CHRO N/A
- Revenue Next Year
- VRME $5.70
- CHRO N/A
- P/E Ratio
- VRME N/A
- CHRO N/A
- Revenue Growth
- VRME N/A
- CHRO N/A
- 52 Week Low
- VRME $0.57
- CHRO $0.45
- 52 Week High
- VRME $5.00
- CHRO $3.80
- Technical
- Relative Strength Index (RSI)
- VRME 35.75
- CHRO 41.12
- Support Level
- VRME $0.57
- CHRO $1.44
- Resistance Level
- VRME $0.75
- CHRO $2.00
- Average True Range (ATR)
- VRME 0.08
- CHRO 0.16
- MACD
- VRME 0.01
- CHRO -0.03
- Stochastic Oscillator
- VRME 31.54
- CHRO 9.37
About VRME VerifyMe Inc.
VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.